Beam Therapeutics Inc.
HealthcareNASDAQ:BEAM · NASDAQ Global Select
-$0.38 today
Vol 1.57M · Avg 2.10M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+70.16%
Period High
$35.41
Period Low
$16.01
Latest
$29.03
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
ImmunityBio, Inc.
NASDAQ:IBRX
$7.44B
Cogent Biosciences, Inc.
NASDAQ:COGT
$5.66B
Denali Therapeutics Inc.
NASDAQ:DNLI
$3.44B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.55B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
89bio, Inc.
ETNB
$2.20B
Galapagos N.V.
GLPG
$1.84B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$1.75B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.57B
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$1.41B
What is the latest BEAM filing?
The latest filing shown is 8-K dated Jun 8, 2026.
How many recent filings does BEAM have?
Intrinsic Alpha currently shows 20 recent filings for BEAM.
Explore More
Continue the stock analysis
Jump to another research area for this company.